Cohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura Nephritis
NCT02878018 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2019-03-04
Summary
Henoch-Schonlein purpura nephritis(HSPN) is one of the most common secondary glomerulonephritis in children. A large, prospective, multicenter cohort study is being conducted in three institutions. Eligible Henoch-Schönlein purpura nephritis children will be classified as the experimental group (n=300) and the control group (n=300) based on the interventions they receive. Patients taking Chinese herbal formula will be in the experimental group, and those taking Western medicine will be in the control group. The entire study will last 60 weeks, including a 12-week observation period and a followup at 12 months.
Conditions
- Henoch-Schonlein Purpura Nephritis
Interventions
- DRUG
-
Qi-Ji Shen-Kang formula; Zhu-Bai formula; Yu-Shen formula
Qi-Ji Shen-Kang formula:15g of field thistle,10g of common edelweiss herb,10g of spreading hedyotis herb,10g ofYunnan manyleaf Paris rhizome,10g of hairyvein agrimonia herb,10g of the root bark of the tree peony,15g of root of red rooted salvia, and 15g ofmembranous mikvetch root.Zhu-Bai formula:10g of glabrous greenbrier rhizome,5g of Chinese atractylodes rhizome,10g of amur corktree bark,10g of common edelweiss her),10g of field thistle,10g of lalang grass rhizome,10g of garden burnet root,5g of longbract cattail pollen,5g of rehmanniae radix, and 5g of Chinese angelica root.Yu-Shen formula:15g of membranous mikvetch root,10g of heterophylla falsestarwort root,10g of field thistle,10g of cogongrass rhizome,10g of spreading hedyotis herb,10g of root of red rooted salvia,10g of fresh root of rehmannia,10g of Asian puccoon,10g of wormwoodlike motherwort herb,10g of common cockscomb inflorescence,10g of gordon euyale,10g of root bark of the tree peony, and 5g of licorice root.
- DRUG
-
angiotensin-converting enzyme (ACE) inhibitor; adrenergic receptor binder (ARB); adrenal cortical hormone; Tripterygium wilfordii polyglycosidium; immunosuppressant
prednisone at a dose of 1-1.5 mg/(kg·d) and Tripterygium wilfordii polyglycosidium at a dose of 1 mg/(kg·d). For each patient, the specific Western medicines used and their doses may be adjusted at the discretion of his or her physician, but the classes cannot be changed.
Sponsors & Collaborators
-
First Hospital of China Medical University
collaborator OTHER -
Shengjing Hospital
collaborator OTHER -
Liaoning University of Traditional Chinese Medicine
lead OTHER
Principal Investigators
-
jun zhang, master · Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
-
jing lv, master · Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
-
shaoqing zhang, doctor · Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
-
guanqi yang, doctor · Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
-
shuang pang, doctor · Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
-
binyu wu, master · Shengjing Hospital
-
yaoguo zhang, master · First Hospital of China Medical University
Eligibility
- Min Age
- 5 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-30
- Primary Completion
- 2019-03-31
- Completion
- 2020-05-31
Countries
- China
Study Locations
More Related Trials
-
The Efficacy of Huaiqihuang Granule in Children With Primary Nephrotic Syndrome
NCT03332420 ·Status: COMPLETED
-
YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study2
NCT07034807 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Clinical Research of Traditional Chinese Medicine Compound Formulas
NCT07153731 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effectiveness Study of Integrative Treatment for Pediatric Pneumonia
NCT02069665 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy
NCT02231125 ·Status: UNKNOWN ·Phase: PHASE4
-
the Integrated Traditional Chinese and Western Medicine Treat Early Stage DKD
NCT03681704 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease
NCT02231138 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Trial of Experienced Chinese Herbal Formulas on Different Types of Precocious Puberty
NCT02650141 ·Status: COMPLETED ·Phase: NA
-
Effectiveness Study of Integrative Treatment for Pediatric Community Acquired Pneumonia
NCT02362906 ·Status: UNKNOWN ·Phase: NA
-
Shensong Yangxin Capsule in the Treatment of Heart Failure Complicated With Ventricular Premature Beat
NCT01612260 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of the Effects of Chinese Herbal Medicine on Chronic Urticaria
NCT01715740 ·Status: COMPLETED ·Phase: PHASE3
-
Cohort Study on the Treatment of Severe Pneumonia with Traditional Chinese Medicine
NCT06613659 ·Status: NOT_YET_RECRUITING
-
Modified Xiao-Feng Powder for Chronic Urticaria
NCT04967092 ·Status: UNKNOWN ·Phase: PHASE2
-
Indicators and Evaluation of Efficacy of Yin-nourishing and Fire-reducing Chinese Medicine for Girls With Rapid Progression of Early Puberty
NCT06820931 ·Status: RECRUITING ·Phase: PHASE4
-
REspiratory diSEAse cohoRt Studies of CHinese Medicine for Pneumonia (RESEARCH-Pneumonia)
NCT06220019 ·Status: NOT_YET_RECRUITING
-
Clinical Study on the Efficacy and Safety of Qingre Heji in the Treatment of Acute Upper Respiratory Tract Infection
NCT06520618 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combined Western and Traditional Chinese Medicine Daycare for DM Nephropathy Patients
NCT05038046 ·Status: COMPLETED ·Phase: PHASE3
-
Traditional Chinese Medicine Combined With Standard Triple Region for Eradication of Helicobacter Pylori
NCT02803216 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Preliminary Randomized Study of Tianjiu (Auto-moxibustion) Effects in Patients With Intradialytic Hypotension
NCT02210377 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluate the Effect and Safety of Pu Yang Wan Wu Tang and Western Medicine on Chronic Kidney Disease
NCT05387187 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
the Integrated Traditional Chinese and Western Medicine Treat Middle Stage DKD
NCT03681249 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Chinese Herbal Medicine for Dialysis-related Myofascial Pain: Study Protocol for A Pilot Randomized Study
NCT04417101 ·Status: UNKNOWN ·Phase: PHASE2
-
Research on the Clinical Effect of Effective Prescription in Treating Unstable Angina.
NCT03171597 ·Status: UNKNOWN ·Phase: PHASE4
-
Chinese Medicine for Treating Chronic Pharyngolaryngitis
NCT05665777 ·Status: UNKNOWN ·Phase: PHASE2
-
Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions
NCT01750775 ·Status: UNKNOWN ·Phase: PHASE4